Full Text View
Tabular View
No Study Results Posted
Related Studies
Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder
This study is currently recruiting participants.
Study NCT00143767   Information provided by UMC Utrecht
First Received: August 31, 2005   Last Updated: March 18, 2007   History of Changes

August 31, 2005
March 18, 2007
August 2005
 
 
 
Complete list of historical versions of study NCT00143767 on ClinicalTrials.gov Archive Site
 
 
 
Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder
Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder

The primary purpose of this study is to investigate brain whether ADHD represents a disruption or a delay of brain development. Children and adolescents both with and without ADHD are asked to participate in several MRI sessions, two years apart. This will allow us to chart brain development over time, both in typical development and ADHD, and therefore to address whether ADHD represents a disruption or a delay of typical brain development.

Attention Deficit Hyperactivity Disorder (ADHD) is a common and impairing neuropsychiatric disorder of childhood, occurring in 3 to 5% of all school-age children. This disorder is associated with greater risks for low academic achievement, school dropouts, poor family and peer relations, aggression, substance abuse, driving accidents and chronic problems in adult adaptation. As such, it has an enormous impact on the utilization of medical and health care services, and the direct and indirect costs of this disorder are high. However, in a large number of children symptoms dissipate as they grow up and they go on to function normally and lead typical lives. This has lead to speculation that ADHD may not so much represent a disruption, as a delay of brain development. This aim of this study is to address this issue.

There is a growing body of research supporting the existence of deficits in brain anatomy associated with ADHD, with evidence of reductions in overall brain size, cortical gray matter and subcortical structures. However, reported effect sizes are small and results not always consistent. Anatomical MRI studies may be easily confounded, as brain development is complex and associated with both progressive and regressive changes in brain anatomy. In this study, we propose to combine longitudinal data from a large cohort of children and adolescents with state-of-the-art imaging methods (including diffusion tensor imaging and voxelbased morphometry) to investigate brain development in ADHD. This will allow us to address the question whether ADHD represents a disruption or a delay of brain development.

 
Observational
Natural History, Longitudinal, Case Control, Prospective Study
Attention Deficit Hyperactivity Disorder
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
400
 
 

Inclusion Criteria:

  • Aged 6 - 18 years at initial MRI

Inclusion Criteria for Subjects with ADHD:

  • DSM-IV (APA, 1994) diagnosis of ADHD, according to DISC interview
  • Scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form(TRF)

Inclusion Criteria for Controls:

  • No DSM-IV (APA, 1994) diagnosis, according to DISC interview
  • No scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF)

Exclusion Criteria:

  • IQ < 70
  • Major illness of the cardiovascular, the endocrine, the pulmonal or the gastrointestinal system
  • Presence of metal objects in or around the body (pacemaker, dental braces)
  • History of or present neurological disorder
  • For individuals over 12 years of age: legal incompetence, defined as the obvious inability to comprehend the information that is presented by the investigator and is outlined in the Information letter and on which the decision to participate in the study is to be based
Both
6 Years to 20 Years
Yes
Contact: Sarah Durston, Ph.D. +31 30 250 8161 S.Durston@umcutrecht.nl
Netherlands
 
NCT00143767
 
METC 05/036
UMC Utrecht
 
Principal Investigator: Sarah Durston, Ph.D. Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht
Study Chair: Herman van Engeland, M.D. Ph.D. Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht
UMC Utrecht
March 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP